| Histiocytic sarcoma in 14 miniature schnauzers–a new breed predisposition? JA Lenz, E Furrow, LE Craig, CM Cannon Journal of Small Animal Practice 58 (8), 461-467, 2017 | 27 | 2017 |
| Vinblastine as a second rescue for the treatment of canine multicentric lymphoma in 39 cases (2005 to 2014) JA Lenz, CS Robat, TJ Stein Journal of small animal practice 57 (8), 429-434, 2016 | 18 | 2016 |
| Aortic tear and dissection related to connective tissues abnormalities resembling Marfan syndrome in a Great Dane JA Lenz, JF Bach, CM Bell, RL Stepien Journal of Veterinary Cardiology 17 (2), 134-141, 2015 | 16 | 2015 |
| Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma JA Lenz, CA Assenmacher, V Costa, K Louka, S Rau, NS Keuler, ... Cancer Immunology, Immunotherapy 71 (4), 807-818, 2022 | 11 | 2022 |
| Response‐based modification of CHOP chemotherapy for canine B‐cell lymphoma SE Benjamin, KU Sorenmo, EL Krick, P Salah, KA Walsh, NM Weinstein, ... Veterinary and Comparative Oncology 19 (3), 541-550, 2021 | 10 | 2021 |
| Extracellular vesicles secreted by tumor cells promote the generation of suppressive monocytes N Luong, JA Lenz, JF Modiano, JK Olson Immunohorizons 5 (8), 647-658, 2021 | 9 | 2021 |
| Mycoplasma infection of the middle ear in three cats AL Ackermann, JA Lenz, ER May, LA Frank Veterinary dermatology 28 (4), 417-e102, 2017 | 8 | 2017 |
| Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic … A Gedney, P Salah, JA Mahoney, E Krick, R Martins, H Scavello, JA Lenz, ... Veterinary and Comparative Oncology 20 (3), 688-696, 2022 | 5 | 2022 |
| Sarcomas—A barren immunological wasteland or field of opportunity for immunotherapy? MJ Atherton, JA Lenz, NJ Mason Veterinary and Comparative Oncology 18 (4), 447-470, 2020 | 4 | 2020 |
| Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: a retrospective study SA Kenny, MR Cook, JA Lenz, KC Maritato, KA Skorupski, ... Veterinary and Comparative Oncology 21 (4), 587-594, 2023 | 2 | 2023 |
| Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma K Zimmerman, KA Walsh, JT Ferrari, NS Keuler, MJ Atherton, JA Lenz Veterinary and Comparative Oncology 21 (3), 503-508, 2023 | 2 | 2023 |
| Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy JA Lenz, SE Benjamin, KA Walsh, NS Keuler, MJ Atherton Veterinary and Comparative Oncology 21 (2), 339-348, 2023 | 1 | 2023 |
| Malignant transformation and subsequent leptomeningeal carcinomatosis of a gastric polyp in a dog DS Didehvar, MR Lanza, MJ Atherton, JA Lenz Journal of Veterinary Internal Medicine 38 (3), 1744-1750, 2024 | | 2024 |
| Quantification of CD3, FoxP3, and granzyme B immunostaining in canine renal cell carcinoma A Cournoyer, H Amerman, CA Assenmacher, A Durham, JA Perry, ... Veterinary Immunology and Immunopathology 271, 110741, 2024 | | 2024 |
| Resolution of paraneoplastic hypoglycemia following nephroureterectomy for treatment of canine renal cell carcinoma: Case report Y Huerta, J Lenz, B Flesner, B Abrams, H Amerman, M Griffin Frontiers in Veterinary Science 10, 1134098, 2023 | | 2023 |
| Immune transcriptional profiling in a large animal model of histiocytic sarcoma reveals putative drivers and tumor suppressors JA Lenz, CA Assenmacher, E Radaelli, MJ Atherton Cancer Research 82 (12_Supplement), 1344-1344, 2022 | | 2022 |
